Greater negative lymph node count predicts favorable survival of patients with breast cancer in the setting of neoadjuvant chemotherapy and mastectomy.

Aim: Adequate lymph node evaluation is recommended in patients with malignant tumors. However, the role of negative lymph nodes (NLNs) remains unclear in breast cancer (BC), especially in patients who have received neoadjuvant chemotherapy and mastectomy. Materials & methods: A total of 435 patients were included in the analysis. On multivariate analysis, NLN count was an independent predictor of 5 year disease-free survival and 5 year overall survival. Results: Patients with NLN count <10 showed significantly worse 5 year disease-free survival than those with NLN count ≥10 (34.8 and 78.2%; p = 0.000); the corresponding 5 year overall survival rates were also significantly different (52.0 and 82.7%; p = 0.000). Conclusion: This is the first study that confirms the relationship between NLN count and prognosis of patients in the setting of neoadjuvant chemotherapy and mastectomy. More NLNs imply better prognosis.

[1]  Vivek Verma,et al.  Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy , 2018, Breast Cancer Research and Treatment.

[2]  Pei Wang,et al.  Increasing negative lymph node count predicts favorable OS and DSS in breast cancer with different lymph node-positive subgroups , 2018, PloS one.

[3]  Q. Lv,et al.  The value of positive lymph nodes ratio combined with negative lymph node count in prediction of breast cancer survival. , 2017, Journal of thoracic disease.

[4]  D. Berry,et al.  Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance) , 2016, Breast Cancer Research and Treatment.

[5]  J. Reis-Filho,et al.  Translating neoadjuvant therapy into survival benefits: one size does not fit all , 2016, Nature Reviews Clinical Oncology.

[6]  S. Masood.  Neoadjuvant chemotherapy in breast cancers , 2016, Women's health.

[7]  Daniel F Hayes,et al.  Neoadjuvant Chemotherapy: What Are the Benefits for the Patient and for the Investigator? , 2015, Journal of the National Cancer Institute. Monographs.

[8]  San-Gang Wu,et al.  Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer , 2015, BMC Cancer.

[9]  S. Loibl,et al.  Surgical treatment of primary breast cancer in the neoadjuvant setting , 2014, The British journal of surgery.

[10]  Menghong Sun,et al.  Number of Negative Lymph Nodes is Associated with Survival in Thoracic Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy , 2014, Annals of Surgical Oncology.

[11]  S. Mclaughlin,et al.  Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. , 2013, JAMA.

[12]  T. Fehm,et al.  Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. , 2013, The Lancet. Oncology.

[13]  Ying Chen,et al.  Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patients , 2013, Cancer Cell International.

[14]  Stewart J Anderson,et al.  Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Dan Sun,et al.  Enhancement the Prediction of Postoperative Survival in Gastric Cancer by Combining the Negative Lymph Node Count with Ratio Between Positive and Examined Lymph Nodes , 2010, Annals of Surgical Oncology.

[16]  J. Meyerhardt,et al.  Negative Lymph Node Count Is Associated With Survival of Colorectal Cancer Patients, Independent of Tumoral Molecular Alterations and Lymphocytic Reaction , 2010, The American Journal of Gastroenterology.

[17]  P. V. van Diest,et al.  Micrometastases or isolated tumor cells and the outcome of breast cancer. , 2009, The New England journal of medicine.

[18]  J. Galon,et al.  The essential role of the in situ immune reaction in human colorectal cancer , 2008, Journal of leukocyte biology.

[19]  B. Iacopetta,et al.  Tumor-Infiltrating Lymphocytes and Perforation in Colon Cancer Predict Positive Response to 5-Fluorouracil Chemotherapy , 2008, Clinical Cancer Research.

[20]  Francesco D'Angelo,et al.  Classification of Lymph Node Metastases from Gastric Cancer: Comparison between N-Site and N-Number Systems. Our Experience and Review of the Literature , 2007, The American surgeon.

[21]  David D. Smith,et al.  Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage , 2007, Annals of Surgical Oncology.

[22]  B. Kuru.  Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  S. Iacobelli,et al.  Axillary Lymph Node Nanometastases Are Prognostic Factors for Disease-Free Survival and Metastatic Relapse in Breast Cancer Patients , 2006, Clinical Cancer Research.

[24]  N. Baxter,et al.  Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  R. Otter,et al.  The Prognostic Effect of the Number of Histologically Examined Axillary Lymph Nodes in Breast Cancer: Stage Migration or Age Association? , 2006, Annals of Surgical Oncology.

[26]  Hiba A. Mohammed,et al.  Sentinel lymph nodes and breast carcinoma: analysis of 70 cases by frozen section , 2005, Annals of Saudi medicine.

[27]  K. Tsugawa,et al.  Quantitative evaluation of metastases in axillary lymph nodes of breast cancer , 2003, British Journal of Cancer.

[28]  G. Storme,et al.  Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. , 2003, International journal of oncology.